Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Melanoma Research|June 5, 2004
Concurrent adjuvant radiotherapy and interferon-alpha2b for resected high risk stage III melanoma -- a retrospective single centre studyDavid E Gyorki, Jill Ainslie, Michael Lim Joon, et al.
Cells|November 4, 2020
Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-AnalysisEmmanuel Acheampong, Afaf Abed, Michael Morici, et al.
Pigment Cell & Melanoma Research|December 22, 2016
Clinical and therapeutic implications of BRAF mutation heterogeneity in metastatic melanomaNima Mesbah Ardakani, Connull Leslie, Fabienne Grieu-Iacopetta, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2022
Human leucocyte antigen genotype association with the development of immune-related adverse events in patients with non-small cell lung cancer treated with single agent immunotherapyAfaf Abed, Ngie Law, Leslie Calapre, et al.
ANZ Journal of Surgery|November 3, 2009
Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapyJohn M Alvarez, Arman Hasani, Amanda Segal, et al.
Cancer|October 29, 2009
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanomaTim Eisen, Uwe Trefzer, Anne Hamilton, et al.
Frontiers in Oncology|July 23, 2020
Role of Serum Vascular Endothelial Growth Factor (VEGF) as a Potential Biomarker of Response to Immune Checkpoint Inhibitor Therapy in Advanced Melanoma: Results of a Pilot StudyMuhammad A Khattak, Afaf Abed, Anna L Reid, et al.
Pathology|August 27, 2015
FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitorConnull Leslie, Samantha E Bowyer, Alison White, et al.
The Journal of Molecular Diagnostics : JMD|August 31, 2015
Mutational Analysis of BRAF Inhibitor-Associated Squamoproliferative LesionsBritt Clynick, Tania Tabone, Kathryn Fuller, et al.
Scientific Reports|December 22, 2018
Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous MelanomaYing Dunkel, Anna L Reid, Jason Ear, et al.
Pageof 15